These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response. de Matos LP; Santana CV; Souza RP Psychiatry Res; 2015 Sep; 229(1-2):586-8. PubMed ID: 26213377 [TBL] [Abstract][Full Text] [Related]
5. Association of dopamine receptor D1 (DRD1) polymorphisms with risperidone treatment response in Chinese schizophrenia patients. Huo R; Wei Z; Xiong Y; Jiang J; Liu Y; Yan Y; Shi J; Li W; Cui D; Xing Q; He L; Qin S Neurosci Lett; 2015 Jan; 584():178-83. PubMed ID: 25179995 [TBL] [Abstract][Full Text] [Related]
6. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Masellis M; Basile V; Meltzer HY; Lieberman JA; Sevy S; Macciardi FM; Cola P; Howard A; Badri F; Nöthen MM; Kalow W; Kennedy JL Neuropsychopharmacology; 1998 Aug; 19(2):123-32. PubMed ID: 9629566 [TBL] [Abstract][Full Text] [Related]
7. [Association analysis between dopamine D1 receptor gene and symptom quantitative trait of schizophrenia]. Zhang C; Wu ZG; Shao Y; Li ZZ; Yu SY; Fang YR Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(29):2019-22. PubMed ID: 22093926 [TBL] [Abstract][Full Text] [Related]
8. Effect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant. Hwang R; Zai C; Tiwari A; Müller DJ; Arranz MJ; Morris AG; McKenna PJ; Munro J; Potkin SG; Lieberman JA; Meltzer HY; Kennedy JL Pharmacogenomics J; 2010 Jun; 10(3):200-18. PubMed ID: 20029384 [TBL] [Abstract][Full Text] [Related]
9. Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated region. Greenbaum L; Smith RC; Rigbi A; Strous R; Teltsh O; Kanyas K; Korner M; Lancet D; Ben-Asher E; Lerer B Pharmacogenomics J; 2009 Apr; 9(2):103-10. PubMed ID: 18347610 [TBL] [Abstract][Full Text] [Related]
10. Analysis of genetic variations in the dopamine D1 receptor (DRD1) gene and antipsychotics-induced tardive dyskinesia in schizophrenia. Lai IC; Mo GH; Chen ML; Wang YC; Chen JY; Liao DL; Bai YM; Lin CC; Chen TT; Liou YJ Eur J Clin Pharmacol; 2011 Apr; 67(4):383-388. PubMed ID: 21181138 [TBL] [Abstract][Full Text] [Related]
11. Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia. Hoenicka J; Garrido E; Ponce G; Rodríguez-Jiménez R; Martínez I; Rubio G; Jiménez-Arriero MA; Palomo T Am J Med Genet B Neuropsychiatr Genet; 2010 Jun; 153B(4):948-54. PubMed ID: 20127886 [TBL] [Abstract][Full Text] [Related]
12. DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs. Ota VK; Spíndola LN; Gadelha A; dos Santos Filho AF; Santoro ML; Christofolini DM; Bellucco FT; Ribeiro-dos-Santos ÂK; Santos S; Mari Jde J; Melaragno MI; Bressan RA; Smith Mde A; Belangero SI Schizophr Res; 2012 Dec; 142(1-3):206-8. PubMed ID: 23036699 [TBL] [Abstract][Full Text] [Related]
13. An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia. Zhu F; Yan CX; Wang Q; Zhu YS; Zhao Y; Huang J; Zhang HB; Gao CG; Li SB Brain Res; 2011 Oct; 1420():106-13. PubMed ID: 21955727 [TBL] [Abstract][Full Text] [Related]
14. Significant association of DRD1 with nicotine dependence. Huang W; Ma JZ; Payne TJ; Beuten J; Dupont RT; Li MD Hum Genet; 2008 Mar; 123(2):133-40. PubMed ID: 18092181 [TBL] [Abstract][Full Text] [Related]
15. No genetic association between dopamine D1 receptor gene and [early onset] schizophrenia. Zhang C; Fang Y; Xie B; Cheng W; Du Y; Wang D; Yu S Psychiatry Res; 2010 May; 177(3):350-3. PubMed ID: 20382433 [TBL] [Abstract][Full Text] [Related]
16. The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation. Zuo L; Luo X; Krystal JH; Cramer J; Charney DS; Gelernter J Pharmacogenet Genomics; 2009 Jun; 19(6):437-46. PubMed ID: 19369910 [TBL] [Abstract][Full Text] [Related]
18. Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients. Tiwari AK; Zai CC; Meltzer HY; Lieberman JA; Müller DJ; Kennedy JL Hum Psychopharmacol; 2010 Apr; 25(3):253-9. PubMed ID: 20373477 [TBL] [Abstract][Full Text] [Related]
19. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Xu K; Lichtermann D; Lipsky RH; Franke P; Liu X; Hu Y; Cao L; Schwab SG; Wildenauer DB; Bau CH; Ferro E; Astor W; Finch T; Terry J; Taubman J; Maier W; Goldman D Arch Gen Psychiatry; 2004 Jun; 61(6):597-606. PubMed ID: 15184239 [TBL] [Abstract][Full Text] [Related]
20. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]